Unlocking mRNA-LNP Potential Using a Novel Lipid Library Combined to Innovative Analytical Methods
On-Demand
Lipid nanoparticles (LNPs) have emerged as a versatile platform for RNA delivery, finding extensive use in both in vivo and ex vivo applications such as prophylactic and therapeutic vaccines, gene editing, protein replacement therapies and genetically modified cell therapies. Despite their numerous advantages, LNPs still exhibit some limitations, notably their tendency to accumulate in the liver, causing loss of efficiency and off-target effects. Addressing this challenge is a top priority within the field, as it holds the key to unlocking the full therapeutic potential of these innovative treatments. In addition, post-formulation, LNPs require downstream processing and monitoring of Critical Quality Attributes (CQAs). Accurate and reliable analytical methods are therefore essential to ensure the quality, efficacy, and safety of LNPs in various applications.
In this webinar, we showcase the utilization of our innovative library of imidazolium-based lipids in the formulation of LNPs, highlighting their potential to fully replace or complement ionizable lipids. We will present comprehensive characterization data of the LNPs produced and emphasize the value of screening the library to identify the best suited lipid formulations for specific therapeutic objectives.
Furthermore, we highlight how utilizing liquid chromatography as an analytical tool, researchers and formulation scientists can gain valuable insights into the encapsulation efficiency, lipid composition and quantification, load integrity and size of LNPs loaded with nucleic acids. These analytical methods contribute to the development of robust and efficient LNP drug products, ultimately enhancing the therapeutic outcomes of nucleic acid-based therapies.
What You Will Learn:
- Optimizing LNP formulations and enable their comprehensive analysis
- Benefits of innovative lipids on the properties of LNPs, as a total replacement for the ionizable lipid or as a complement
- New solutions for RNA therapeutics developers seeking to cure extrahepatic diseases or avoid off-target hepatic effects
- Reverse-phase chromatography for LNPs analysis
- 2D chromatography for direct analysis of LNP formulation, with no sample pretreatment